PLAT and stroke disorder: Despite an emphasis on implementing effective acute and chronic stroke care made by the American Heart Association and American Stroke Association, there are only two FDA-approved treatment options available for acute stroke: tissue plasminogen activator (tPA) and endovascular thrombectomy.